Medicinal Chemistry Support Program for Therapeutic Development (MCSP)

Added: Mar 19, 2018 2:41 pm This contract is for services to NINDS and the Blueprint Neurotherapeutics Network (BPN) to provide a full service, turn-key medicinal chemistry operation for the development of therapeutics within the mission of NINDS, BPN and other NIH Institutes and Centers (ICs).

The ID/IQ contract has been awarded with a ten (10) year ordering period of March 16, 2018 through March 15, 2028. The minimum award amount is $17,186; the maximum award amount under this program is $39,500,000. AMRI has also been awarded a task order concurrent with the parent ID/IQ contract. This task order covers the first year of performance under the "Tech Transfer, Storage Handling and Distribution, Access Training and IT Security Relevant to Existing Compound Repository" component of the program. The period of performance of this task order award is March 16, 2018 through March 15, 2019 with an award amount of $17,186. The task order award also contains nine (9) additional 12-month term options which have been negotiated as follows:

Option Option Period
#1 - Term Extension Year 2 - March 2019 - March 2020
#2 - Term Extension Year 3 - March 2020 - March 2021
#3 - Term Extension Year 4 - March 2021 - March 2022
#4 - Term Extension Year 5 - March 2022 - March 2023
#5 - Term Extension Year 6 - March 2023 - March 2024
#6 - Term Extension Year 7 - March 2024 - March 2025
#7 - Term Extension Year 8 - March 2025 - March 2026
#8 - Term Extension Year 9 - March 2026 - March 2027
#9 - Term Extension Year 10 - March 2027 - March 2028

Task Orders for Performance Area 2, "Medicinal Chemistry Support (MCS)", for individual MCS studies will be awarded through a Task Order Request for Proposals (TORFPs) process as the need arises. It is anticipated that these task orders will be cost-reimbursement, completion-type task orders and will have variable periods of performance.